Cimicifuga racemosa (CR) safety: Pre- and clinical evidence for lack of widespread estrogenic risk
Garcia de Arriba, S, Henneicke-von Zepelin, H.H, Naser, B, Nolte, K.U
Published in Maturitas (01.11.2015)
Published in Maturitas (01.11.2015)
Get full text
Journal Article
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia
Von Wussow, P, Hehlmann, R, Hochhaus, T, Jakschies, D, Nolte, K U, Prümmer, O, Ansari, H, Hasford, J, Heimpel, H, Deicher, H
Published in Journal of interferon research (01.08.1994)
Published in Journal of interferon research (01.08.1994)
Get more information
Journal Article
Different specificities of SLE-derived and therapy-induced interferon-alpha antibodies
Nolte, K U, Jakschies, D, Pestka, S, Von Wussow, P
Published in Journal of interferon research (01.08.1994)
Published in Journal of interferon research (01.08.1994)
Get more information
Journal Article